Back to search
Meningococcal Meningitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Meningococcal Meningitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Meningococcal Meningitis trials you may qualify forBacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibil…
Sexual differences are a well-established source of biological variation in immune system functioning, with men often displaying lower adaptive immune responses…
This clinical trial is conducted in two parts. Part One employs a randomized, partially blinded, dose-escalation, partially active-controlled design. Part Two u…
The bacterium (germ) Neisseria meningitidis causes meningitis and blood poisoning. N meningitidis is classified into different serogroups (types), based on its…
The main purpose of this study is to evaluate the immune response and safety of a booster dose of the meningococcal group B vaccine, rMenB+OMV NZ (also known as…